3 hours Amicus Therapeutics, Inc. (NASDAQ:FOLD) to Post Q2 2025 Earnings of $0.01 Per Share, Zacks Research ForecastsMarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) – Investment analysts at Zacks Research issued their Q2 2025 EPS estimates for shares of Amicus Therapeutics in a report released on Wednesday, October 16th. Zacks Research analyst R. Department …
Earnings · Nasdaq 100 · Science
X